12.05.2020 • NewsLuciteAgilyxElaine Burridge

Lucite and Agilyx Partner on PMMA

Acrylic-based products manufacturer Lucite International, part of the Mitsubishi Chemical Group, is working with Agilyx to define the most suitable chemical recycling infrastructure for polymethyl methacrylate (PMMA).

Agilyx will apply its depolymerization process to produce a virgin-quality monomer, or methyl methacrylate (MMA).

Lucite’s aim is to bring the technology to commercial realization by 2023, giving PMMA producers the ability to have their products recovered and recycled while also offering consumers fully recycled acrylic products.

In the interim, the UK-based acrylics specialist said it will work with all key stakeholders, including MMA and PMMA customers, manufacturers, distributors, fabricators and recyclers to develop a robust value chain.

Phil Bailey, general manager EMEA strategic business unit at Mitsubishi Chemical, said the company is “committed to ensuring PMMA becomes a fully sustainable material.” He added: “We know from our customers that there is great demand for this, driven by societal and environmental concerns. As global leaders in the MMA industry, we have a responsibility to take the lead in this area.”

In March this year, Lucite announced it would build a 350,000 t/y MMA plant in the US, taking advantage of the country’s favorable shale gas feedstock position. The project, which will use Lucite’s proprietary Alpha technology, is currently in the design phase and expected to be fully operational in 2025.

The company added that the plant will be the third and largest commercial application of its Alpha technology since it was developed and successfully implemented in 2008. It will be fully owned and operated by Mitsubishi Chemical.

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.

Innovation Pitch

The Start-up Platform for Chemistry & Life Sciences
Discover Tomorrow’s Innovators

The Start-up Platform for Chemistry & Life Sciences

CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.

most read

Photo
13.03.2025 • News

Roche and Zealand Pharma Collaborate on Weight Management Drug

Swiss pharma heavyweight Roche announced has entered into an exclusive collaboration and licensing agreement with Denmark’s Zealand Pharma. Under the terms of this agreement, the two companies will collaborate to co-develop and co-commercialize petrelintide, Zealand Pharma’s amylin analog as a standalone therapy as well as a fixed-dose combination with Roche’s lead incretin asset CT-388.

Photo
22.04.2025 • News

BASF Divests Two Joint Ventures in China

BASF has divested its shares in the joint venture companies, BASF Markor Chemical Manufacturing (Xinjiang) Co., Ltd. and Markor Meiou Chemical (Xinjiang) Co., Ltd. in Korla, China, to Verde Chemical Singapore Pte. Ltd.